These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. LC3, an autophagosome marker, is expressed on oligodendrocytes in Nasu-Hakola disease brains. Satoh J; Motohashi N; Kino Y; Ishida T; Yagishita S; Jinnai K; Arai N; Nakamagoe K; Tamaoka A; Saito Y; Arima K Orphanet J Rare Dis; 2014 May; 9():68. PubMed ID: 24886140 [TBL] [Abstract][Full Text] [Related]
12. Variable expression of microglial DAP12 and TREM2 genes in Nasu-Hakola disease. Sasaki A; Kakita A; Yoshida K; Konno T; Ikeuchi T; Hayashi S; Matsuo H; Shioda K Neurogenetics; 2015 Oct; 16(4):265-76. PubMed ID: 26001891 [TBL] [Abstract][Full Text] [Related]
13. Targeted sequencing approach to identify genetic mutations in Nasu-Hakola disease. Satoh JI; Yanaizu M; Tosaki Y; Sakai K; Kino Y Intractable Rare Dis Res; 2016 Nov; 5(4):269-274. PubMed ID: 27904822 [TBL] [Abstract][Full Text] [Related]
14. Reactive astrocytes express Aggregatin ( Satoh JI; Kino Y; Yanaizu M; Ishida T; Saito Y Intractable Rare Dis Res; 2020 Nov; 9(4):217-221. PubMed ID: 33139980 [TBL] [Abstract][Full Text] [Related]
15. Defects in lysosomal function and lipid metabolism in human microglia harboring a TREM2 loss of function mutation. Filipello F; You SF; Mirfakhar FS; Mahali S; Bollman B; Acquarone M; Korvatska O; Marsh JA; Sivaraman A; Martinez R; Cantoni C; De Feo L; Ghezzi L; Minaya MA; Renganathan A; Cashikar AG; Satoh JI; Beatty W; Iyer AK; Cella M; Raskind WH; Piccio L; Karch CM Acta Neuropathol; 2023 Jun; 145(6):749-772. PubMed ID: 37115208 [TBL] [Abstract][Full Text] [Related]
16. Phenotypic Expansion in Nasu-Hakola Disease: Immunological Findings in Three Patients and Proposal of a Unifying Pathogenic Hypothesis. Errichiello E; Dardiotis E; Mannino F; Paloneva J; Mattina T; Zuffardi O Front Immunol; 2019; 10():1685. PubMed ID: 31396216 [TBL] [Abstract][Full Text] [Related]
17. Computational saturation mutagenesis to explore the effect of pathogenic mutations on extra-cellular domains of TREM2 associated with Alzheimer's and Nasu-Hakola disease. Swain PS; Panda S; Pati S; Dehury B J Mol Model; 2023 Nov; 29(11):360. PubMed ID: 37924367 [TBL] [Abstract][Full Text] [Related]
18. The TREM2-DAP12 signaling pathway in Nasu-Hakola disease: a molecular genetics perspective. Xing J; Titus AR; Humphrey MB Res Rep Biochem; 2015; 5():89-100. PubMed ID: 26478868 [TBL] [Abstract][Full Text] [Related]
19. A novel mutation in TREM2 gene causing Nasu-Hakola disease and review of the literature. Dardiotis E; Siokas V; Pantazi E; Dardioti M; Rikos D; Xiromerisiou G; Markou A; Papadimitriou D; Speletas M; Hadjigeorgiou GM Neurobiol Aging; 2017 May; 53():194.e13-194.e22. PubMed ID: 28214109 [TBL] [Abstract][Full Text] [Related]
20. C9ORF72 expansion does not affect the phenotype in Nasu-Hakola disease with the DAP12 mutation. Solje E; Hartikainen P; Valori M; Vanninen R; Tiihonen J; Hakola P; Tienari PJ; Remes AM Neurobiol Aging; 2014 Jul; 35(7):1780.e13-7. PubMed ID: 24612676 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]